Page 1250 - Williams Hematology ( PDFDrive )
P. 1250

1224  Part IX:  Lymphocytes and Plasma Cells                       Chapter 80:  Immunodeficiency Diseases            1225




                  in gain-of-function–impaired actin polymerization, causing X-linked   Other abnormal laboratory tests include eosinophilia, abnormal B-cell
                  neutropenia (Chap. 65). 186                           maturation and defective antibody responses to neoantigens,  che-
                                                                                                                      195
                                                                        motactic defects of neutrophils, and reduced lymphocyte proliferation
                  Clinical and Laboratory Features                      to specific antigens.
                  By definition, WAS and XLT patients have congenital thrombocytope-  Most patients with HIES were noted to arise sporadically from unaf-
                  nia in the range of 20,000 to 60,000/μL and microplatelets, but normal   fected, healthy parents. With the advent of improved antibiotic therapy,
                  numbers of megakaryocytes. Hemorrhagic problems may be mild, con-  patients survived into adulthood and had affected children, suggesting
                                                                                    193
                  sisting of bruises and petechiae, or serious, including gastrointestinal   AD inheritance.  This observation was validated by the finding that
                  and central nervous system hemorrhages. Patients with classic WAS are   heterozygous mutations of the gene encoding the transcription factor
                  susceptible to bacterial, fungal, and viral infections.  STAT3 are the cause of AD-HIES. All STAT3 mutations identified to
                                                                        date in patients with AD-HIES are either amino acid substitutions or
                  Treatment                                             in-frame deletions strongly supporting the concept that coexpression of
                  Patients may require antibiotic prophylaxis and IVIG replacement   wild-type and mutant STAT3 protein is required to cause the syndrome.
                  therapy. Immunosuppressive therapy may be needed if autoimmune   The notable lack of nonsense or frameshift mutations strengthens the
                  symptoms occur. Splenectomy ameliorates the bleeding tendency by   notion that AD-HIES is a result of a dominant-negative effect. 196–198  The
                  increasing the number of blood platelets. However, splenectomy sub-  molecular analysis of a large cohort of patients (n = 38) with “classic”
                  stantially increases the risk of septicemia, sometimes in spite of antibi-  HIES and a score of greater than 40 points using the National Insti-
                  otic prophylaxis, and often results in fatal bacterial infections. Because   tutes of Health clinical scoring system, identified STAT3 mutations
                  of the poor long-term outcome of WAS, early allogeneic HSCT is the   in all but one individual. The mutations clustered in three domains
                  treatment of choice. The outcome is excellent if a matched-related or   of the STAT3 protein known to have distinct functional characteris-
                  matched-unrelated donor can be identified, or if a partially matched   tics, the DNA-binding, and the SH2 and the transactivation domains.
                                       187
                  cord blood unit is available.  Haploidentical transplantation is not   This finding suggests that more than one molecular mechanism causes
                  recommended. Patients with XLT have an excellent prognosis, but may   the AD-HIES phenotype. This notion is supported by the observation
                  develop complications including serious bleeding, autoimmune dis-  that mutations in the SH2 domain, but not those in the DNA-binding
                  eases, and malignancies. 144,185  Therefore, allogeneic HSCT for XLT may   domain, affect tyrosine phosphorylation of STAT3, whereas muta-
                  be considered if an appropriate donor is available. Because complete   tions in the DNA-binding domain interfere with nuclear import and
                                                                                   198
                  myeloid and lymphoid engraftment is required to correct all aspects   DNA-binding.  Because STAT3 plays a key role in the development of
                  of WAS/XLT, standard-conditioning using myeloablative protocols   IL-17 producing Th17 cells, AD-HIES patients have a marked decrease
                                                                                           199
                  (busulfan, cyclophosphamide, with or without antithymocyte globulin)   in circulating Th17 cells.  Given that IL-17 plays an important role
                  are required. A European followup study of WAS patients who received   in host defense against extracellular bacteria and fungi and upregu-
                  HSCT reports a strong association of autoimmunity with mixed chime-  lates production of β defensins and S100 proteins by neutrophils,  the
                                                                                                                       200
                  rism, clearly demonstrating that reduced intensity conditioning is not   absence of Th17 cells may directly affect susceptibility to S. aureus and
                  sufficient. 188                                       Candida albicans.
                  WASp-INTERACTING PROTEIN DEFICIENCY                   Treatment
                                                                        To prevent progressive lung destruction, prophylactic antibiotic ther-
                  A syndrome exhibiting symptoms and laboratory abnormalities typical   apy to decrease the frequency of S. aureus infections is important. Anti-
                  for classic WAS has been observed in a female infant with a homozy-  fungal therapy is indicated to prevent recurrent Candida infections. A
                  gous nonsense mutation in  WIPF1 that encodes WASp-interacting   surgical approach to treating chronic lung disease should be avoided, if
                  protein (WIP). The patient presented at 11 days of age with eczema,   possible. Allogeneic HSCT has been performed in a few patients with
                  thrombocytopenia (but normal platelet size) and infections.  Both   variable benefits. 201,202
                                                               189
                  WIP and WASp were absent in patient leukocytes, demonstrating that
                  WIP is required for stabilization of WASp. The patient was successfully
                  transplanted at age 4.5 months.                       Autosomal Recessive Hyperimmunoglobulin E Syndromes
                                                                        In 2004,  a cohort  of 13 patients from consanguineous families were
                  THE HYPERIMMUNOGLOBULIN E SYNDROMES                   reported to have marked eosinophilia, elevated serum IgE levels, eczema,
                                                                        skin abscesses, recurrent bacterial, fungal, and viral infections including
                  Autosomal Dominant Hyperimmunoglobulin E Syndrome     herpes simplex, therapy-resistant molluscum contagiosum, and recur-
                  HIES (or Job syndrome) is a rare AD or sporadic multisystem immuno-  rent varicella zoster. Lymphopenia and decreased lymphocyte prolifera-
                  deficiency characterized by eczema, S. aureus-induced skin abscesses,   tion suggested a significant T-cell defect. In contrast to HIES caused by
                  recurrent pneumonia with abscess and pneumatocele formation,   STAT3 mutations, autosomal recessive hyper-IgE syndrome (AR-HIES)
                                                                   190
                  Candida infections, and skeletal and connective tissue abnormalities.    patients frequently present with neurologic complications but do not
                  In 1966, two girls suffering from eczema, recurrent respiratory tract   develop skeletal abnormalities or postpneumonia pneumatoceles. Most
                  infections, and “cold” staphylococcus skin abscesses were described as   have large deletions in the DOCK8 gene, resulting in absent DOCK8
                  having Job syndrome because of the phenotypic similarity to the biblical   protein. 138,139  (See DOCK8 deficiency in “Other Combined Immunode-
                  figure Job, who had been “smitten with sore boils from the soles of his   ficiencies” above.) Because of a high incidence of malignancies and early
                                                                                               203
                  feet unto his crown.”  Subsequently, patients with similar clinical find-  death, HSCT is recommended.  A single adult patient with eczema;
                                191
                  ings were reported to have very-high serum IgE concentrations  and   moderately elevated serum IgE; a history of bacterial (BCG complica-
                                                                192
                  additional characteristic abnormalities were recognized, including dis-  tions, salmonellosis), fungal, and viral infections, including molluscum
                  tinct facial features, often described as “coarse,” hyperextensive joints,   contagiosum; and a mild T-cell deficiency was found to have a muta-
                  pathologic bone fractures, scoliosis, craniosynostosis, and retained pri-  tion in tyrosine kinase 2 (TYK2), a receptor-associated cytoplasmatic
                  mary teeth. 193,194  Serum IgE levels of greater than 2000 IU/mL have been   tyrosine kinase that plays an important role in multiple cytokine signal-
                  used as arbitrary diagnostic values, but often are greater than 10,000 IU/mL.   ing of T cells. 204






          Kaushansky_chapter 80_p1211-1238.indd   1225                                                                  9/18/15   10:01 AM
   1245   1246   1247   1248   1249   1250   1251   1252   1253   1254   1255